Edition: BP 2025 (Ph. Eur. 11.6 update)<\/p>\n
General Notices<\/p>\n
Action and use<\/strong><\/p>\n Vitamin D analogue (Vitamin D2).<\/p>\n Ergocalciferol Tablets contain Ergocalciferol.<\/p>\n The tablets comply with the requirements stated under Tablets and with the following requirements.<\/p>\n Content of ergocalciferol, C28H44O<\/p>\n 90.0 to 125.0% of the stated amount.<\/p>\n A. In the test for Uniformity of content, the chromatogram obtained with solution (2) shows a peak with the same retention time as the principal peak in the chromatogram obtained with solution (1).<\/p>\n B. Extract one powdered tablet with 5 mL of dichloromethane, filter and to 1 mL of the filtrate add 9 mL of antimony trichloride solution. A brownish red colour is produced.<\/p>\n Uniformity of content<\/p>\n Ergocalciferol Tablets comply with the requirements stated under Tablets using the following method of analysis. Carry out the method for liquid chromatography, Appendix III D, using the following solutions, protected from light.<\/p>\n (1) 0.001% w\/v of ergocalciferol BPCRS in hexane. (a) Use a stainless steel column (20 cm \u00d7 4.6 mm) packed with silica gel for chromatography (5 \u00b5m) (Partisil is suitable). 8 volumes of pentan-1-ol and 992 volumes of hexane.<\/p>\n The test is not valid unless, in the chromatogram obtained with solution (3), the resolution between the peaks corresponding to pre-colecalciferol and trans-colecalciferol is at least 1.0.<\/p>\n Calculate the content of ergocalciferol, C28H44O, in each tablet using the declared content of C28H44O in ergocalciferol BPCRS.<\/p>\n Use the average of the individual results obtained in the test for Uniformity of content.<\/p>\n The label states the equivalent number of IU (International Units) of antirachitic activity (vitamin D) per tablet.<\/p>\n Each \u03bcg of ergocalciferol is equivalent to 40 IU of antirachitic activity (vitamin D).<\/p>\n When calciferol tablets are prescribed or demanded, Colecalciferol Tablets or Ergocalciferol Tablets shall be dispensed or supplied.<\/p>\n","protected":false},"excerpt":{"rendered":" Edition: BP 2025 (Ph. Eur. 11.6 update) General Notices Action and use Vitamin D analogue (Vitamin D2). DEFINITION Ergocalciferol Tablets contain Ergocalciferol. The tablets comply with the requirements stated under Tablets and with the following requirements. Content of ergocalciferol, C28H44O 90.0 to 125.0% of the stated amount. IDENTIFICATION A. In the test for Uniformity of…<\/p>\n","protected":false},"author":5,"featured_media":15026,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[175],"tags":[],"class_list":["post-15024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-formulated-preparations-specific-monographs"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/15024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=15024"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/15024\/revisions"}],"predecessor-version":[{"id":15036,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/15024\/revisions\/15036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/15026"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=15024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=15024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=15024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}DEFINITION<\/h2>\n
IDENTIFICATION<\/h2>\n
TESTS<\/h2>\n
(2) For tablets containing more than 0.25 mg of Ergocalciferol prepare the solution in the following manner. Add 4 mL of water to one tablet in an amber flask and disperse with the aid of ultrasound. Add 12 mL of dimethyl sulfoxide, mix, extract with 100 mL of hexane by shaking for 30 minutes, centrifuge the hexane layer and use the clear supernatant liquid. For tablets containing 0.25 mg of Ergocalciferol or less carry out the same procedure but using 2 mL of water, 6 mL of dimethyl sulfoxide and 25 mL of hexane.
(3) Dissolve 5 mg of colecalciferol BPCRS in hexane and dilute to 20 mL with the same solvent. Heat in a water-bath at 90\u00b0 under a reflux condenser for 45 minutes and cool (formation of pre-colecalciferol). Dissolve the contents of a vial of cholecalciferol impurity A EPCRS in 1.0 mL of this solution.<\/p>\nCHROMATOGRAPHIC CONDITIONS<\/h3>\n
(b) Use isocratic elution and the mobile phase described below.
(c) Use a flow rate of 2 mL per minute.
(d) Use an ambient column temperature.
(e) Use a detection wavelength of 254 nm.
(f) Inject 20 \u00b5L of each solution.
(g) Allow the chromatography to proceed for twice the retention time of the principal peak.<\/p>\nMOBILE PHASE<\/h3>\n
SYSTEM SUITABILITY<\/h3>\n
DETERMINATION OF CONTENT<\/h3>\n
ASSAY<\/h2>\n
LABELLING<\/h2>\n